Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 14/20 | 0.47 |
| ▸ | F2 | P00734 | 2/20 | 0.42 |
| ▸ | BCHE | P06276 | 3/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11200381 | 0.88 | MAOB (0.49) | MAOBBCHEMAOA | |
| SCHEMBL25204850 | 0.88 | GSTP1 (0.38) | MAOBBCHEMAOA | |
| SCHEMBL28398195 | 0.84 | BCHE (0.53) | MAOBBCHECYP4F2CYP4A11MAOA | |
| SCHEMBL13591059 | 0.84 | GSTP1 (0.38) | MAOBBCHEMAOA | |
| SCHEMBL13591054 | 0.84 | GSTP1 (0.38) | MAOBBCHEMAOA | |
| SCHEMBL13591061 | 0.84 | GSTP1 (0.38) | MAOBBCHEMAOA | |
| SCHEMBL28399599 | 0.81 | MAOB (0.57) | MAOBMAOA | |
| SCHEMBL13591057 | 0.81 | GSTP1 (0.42) | MAOBMAOA | |
| SCHEMBL28396007 | 0.80 | MAOB (0.62) | MAOBBCHECYP4F2CYP4A11MAOA | |
| SCHEMBL31163949 | 0.79 | GSTP1 (0.39) | MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240342301-A1 | ANTIBODY-DRUG CONJUGATES | MC SAF (FR) | 2024-10-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240342301-A1 | ANTIBODY-DRUG CONJUGATES | FCGRT, FCGR3B, FCGR2A | MAOB 1148/4885F2 2185/4885BCHE 110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.